Browsing by author "London, Gérard"

Repository

How to publish

Resources

FAQs

Now showing items 1-4 of 4

Biosimilars and biopharmaceuticals: What the nephrologists need to know - A position paper by the ERA-EDTA Council

Covic, Adrián; Cannata Andía, Jorge Benito; Cancarini, Giovanni; Coppo, Rosanna; Frazao, Joao M.; Goldsmith, David; Ronco, Pierre; Spasovski, Goce; Stenvinkel, Peter; Utas, Cengiz; Wiecek, Andrzej; Zoccali, Carmine; London, Gérard (2008)
Cosmos: Abnormalities in the main bone and mineral biochemical parameters are associated with higher risk of mortality

Fernández Martín, José Luis; Locatelli, Francesco; London, Gérard; Gorriz, José Luis; Floege, Jürgen; Ferreira, Aníbal; Covic, Adrián; Memmos, Dimitrios; Bos, Willem-Jan; Nagy, Judit; Cannata Andía, Jorge Benito; COSMOS (2013)
Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: The COSMOS study

Fernández Martín, José Luis; Martínez Camblor, Pablo; Dionisi, María Paula; Floege, Jürgen; Ketteler, Markus; London, Gérard; Locatelli, Francesco; Gorriz, José Luis; Rutkowski, Boleslaw; Ferreira, Aníbal; Bos, Willem-Jan; Covic, Adrián; Rodríguez García, Minerva; Sánchez, José Emilio; Rodríguez Puyol, Diego; Cannata Andía, Jorge Benito (2015)
Use of phosphate-binding agents is associated with a lower risk of mortality

Cannata Andía, Jorge Benito; Fernández Martín, José Luis; Locatelli, Francesco; London, Gérard; Gorriz, José Luis; Floege, Jürgen; FerreKetteler, Markus; Ferreira, Aníbal; Covic, Adrián; Rutkowski, Boleslaw; Sánchez, José Emilio; Martínez Camblor, Pablo; Naves Díaz, Manuel Luis (2013)

Browsing by author "London, Gérard"

Biosimilars and biopharmaceuticals: What the nephrologists need to know - A position paper by the ERA-EDTA Council ﻿

Cosmos: Abnormalities in the main bone and mineral biochemical parameters are associated with higher risk of mortality ﻿

Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: The COSMOS study ﻿

Use of phosphate-binding agents is associated with a lower risk of mortality ﻿

Biosimilars and biopharmaceuticals: What the nephrologists need to know - A position paper by the ERA-EDTA Council

Cosmos: Abnormalities in the main bone and mineral biochemical parameters are associated with higher risk of mortality

Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: The COSMOS study

Use of phosphate-binding agents is associated with a lower risk of mortality